Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma
MR Middleton, P Friedlander, O Hamid, A Daud, R Plummer, N Falotico, B Chyla, F Jiang, E McKeegan, NM Mostafa, M Zhu, J Qian, M McKee, Y Luo, VL Giranda, GA McArthur
Annals of Oncology | OXFORD UNIV PRESS | Published : 2015
This work was supported by AbbVie Inc. AbbVie provided financial support for this study and participated in the design, study conduct, analysis, and interpretation of the data, as well as the writing, review, and approval of this manuscript. No applicable grant numbers apply.